About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,045 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,045 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4301-4320 of 42,045 trials

CompletedGluconeogenesis Rates and Its Precursors in Pediatric SepsisCritically ill children have abnormal utilization of nutrients such as glucose, lipids and protein. Often sick children have increased glucose concentrations in blood.NCT01890928·Dallas, Texas CompletedEffectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead WrinklesEvaluate the effectiveness and safety of the iovera device for the temporary reduction in the appearance of forehead wrinkles.NCT01950065·Roseville, California and 5 others TerminatedSafety and Efficacy of BGP-15 in Patients With Type 2 Diabetes MellitusThis is a safety and dose finding efficacy study to evaluate the effects of BGP-15 over the dose range of 100 mg/day to 400 mg/day.NCT01069965·Los Angeles, California and 29 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedMechanisms of Lipodystrophy in HIV-Infected PateintsThe metabolic and molecular basis of lipodystrophy syndrome in HIV-infected patients is not known.NCT00457665·Dallas, Texas

Not yet recruitingA Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML PatientsA Phase 1b, open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of…NCT07722767·Duarte, California and 2 others

CompletedZevalin (Ibritumomab Tiuxetan) for Early Stage Indolent LymphomasThe goal of this clinical research study is to find out if giving (Rituxan) rituximab with 90Y (ibritumomab tiuxetan) (90 Y Zevalin®) may be effective in treating low-grade…NCT00493467·Houston, Texas

CompletedA Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft RecipientsThis is a Phase II, randomized, double-blind, placebo-controlled study designed to assess the safety and clinical activity of multiple intravenous doses of MCMV5322A/MCMV3068A in…NCT01753167·Los Angeles, California and 38 others

CompletedTo Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17This study was phase 1, randomized, open-label, two-arm, parallel group, single-dose study, which was designed to compare the pharmacokinetics (PK) and safety of CT-P17 SC…NCT04295356·Austin, Texas

WithdrawnAntineoplaston Therapy in Treating Patients With Mantle Cell LymphomaRATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells.NCT00003502·Houston, Texas

CompletedA Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel StudyTreatment of elevated pressure in the eye (Intraocular pressure, or 'IOP') with eye drop medications has been shown to be effective in delaying or preventing the progression of…NCT03216902·Artesia, California and 16 others

TerminatedHydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusThe study is a 2-arm, double blinded, multicenter, 2:1 randomized, placebo controlled clinical trial.NCT03428945·Los Angeles, California and 50 others

Active not recruitingCidofovir Versus Best Supportive Care for Hemorrhagic CystitisThe goal of this clinical research study is to learn if adding cidofovir to the standard of care can improve symptoms of hemorrhagic cystitis caused by the BK virus as compared to…NCT01295645·Houston, Texas

CompletedEffect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of MoxifloxacinThis study will aim to evaluate the effect of therapeutic and supratherapeutic oral doses of GSK3640254 on cardiac conduction compared to placebo and a single oral dose of…NCT04563845·Austin, Texas

CompletedVascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)This study is a phase 3, double-masked, randomized, study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration.NCT00509795·Birmingham, Alabama and 187 others

RecruitingProtein Supplementation During Luteal Phase to Stop Protein DegradationThe purpose of this research is to determine if increasing 12% of daily protein intake during the luteal phase mitigates the potential catabolic effects of progesterone on…NCT07843095·Conroe, Texas and 1 other

CompletedA Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in WomenSB-751689 may alter calcium and phosphate handling at the kidney level.NCT00532077·San Diego, California and 4 others

CompletedMonoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid LevelsThe primary objective was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145) every 2 weeks (Q2W) or every 4 weeks (Q4W), compared with placebo, on the percent…NCT01375777·Birmingham, Alabama and 57 others

CompletedAn Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301The investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-1 receptor (IGF-1R).NCT06179875·Los Angeles, California and 44 others

CompletedA 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia PatientsThis is a Phase 3, open-label, extension trial designed to evaluate the long term safety and efficacy over 3 months of TNX-102 SL tablets taken daily at bedtime for the treatment…NCT02589275·Birmingham, Alabama and 32 others

Active not recruitingStudy of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)The primary objective of this study is to evaluate the safety and tolerability of tarlatamab in combination with YL201 with or without anti-PD-L1.NCT06898957·Irvine, California and 35 others

PreviousPage 216 of 2103Next

Heart Diseasein Texas